Table 2. Main laboratory findings on admission in patients admitted to ICU due to COVID-19 or with SARS-CoV-2 as a comorbidity.
| Variables (units) | Normal range | All patients |
|---|---|---|
| N (%) | – | 61 (100.0) |
| Lymphocytes (%) | 20–40 | 11.9±9.3 |
| CRP (mg/dL) | <0.5 | 13.2±9.1 |
| PCT (ng/mL) | <0.5 | 0.40 (0.15; 0.85) |
| IL-6 (pg/mL) | <7 | 148 (55; 303) |
| D-dimer (µg/mL) | <0.5 | 3.5±3.9 |
| hs-troponin (pg/mL) | <14 | 41.0 (21.5; 102.5) |
| NT-proBNP (pg/mL) | <125 | 1,702 (422; 4,430) |
| LDH (U/L) | <250 | 486 (412; 648) |
| Creatinine (mg/dL) | 0.5–0.9 | 1.7±1.8 |
Data were presented as mean ± standard deviation or median days (IQR) if not otherwise specified. ICU, intensive care unit; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus type 2; CRP, C-reactive protein; PCT, procalcitonin; IL-6, interleukin-6; hs, high sensitive; NT-proBNP, N-terminal pro-B-type natriuretic peptide; LDH, lactate dehydrogenase; IQR, interquartile range.